Related Experiment Video
Updated: Aug 8, 2026

Method for Novel Anti-Cancer Drug Development using Tumor Explants of Surgical Specimens
Published on: July 29, 2011
Evidence, economics, and emotions: the case for temozolomide
1Blood and Cancer Centre, Wellington Hospital, Wellington South. david.hamilton@ccdhb.org.nz
Abstract:
Temozolomide, given as part of first line therapy in the treatment of grade IV astrocytoma, has been shown to improve survival in the short term. The financial cost of the treatment is considerable in New Zealand. This drug provides a good example in the field of oncology of a modern expensive pharmaceutical being a clear improvement over its cheaper predecessors, but it raises the question of what price should be paid to prolong survival in an incurable illness?
Related Concept Videos
The Placebo Effect
Treatment Resistant Cancers
Therapeutic Drug Monitoring: Affecting Factors
Cancer Survival Analysis
Electroconvulsive Therapy
Psychosurgery
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...

